Tristel - Asset Resilience Ratio
Tristel (TSTL) has an Asset Resilience Ratio of 13.71% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Tristel's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Tristel to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Tristel's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Tristel.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX6.23 Million | 13.71% |
| Total Liquid Assets | GBX6.23 Million | 13.71% |
Asset Resilience Insights
- Moderate Liquidity: Tristel has 13.71% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Tristel Industry Peers by Asset Resilience Ratio
Compare Tristel's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.74% |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026 |
Medical Instruments & Supplies | 8.17% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for Tristel (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Tristel.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 9.26% | GBX4.20 Million ≈ $511.02 |
GBX45.33 Million ≈ $5.52K |
-3.54pp |
| 2024-06-30 | 12.81% | GBX5.65 Million ≈ $687.44 |
GBX44.11 Million ≈ $5.37K |
+6.93pp |
| 2023-06-30 | 5.88% | GBX2.43 Million ≈ $295.90 |
GBX41.37 Million ≈ $5.03K |
-25.02pp |
| 2019-06-30 | 30.90% | GBX8.80 Million ≈ $1.07K |
GBX28.49 Million ≈ $3.47K |
+33.08pp |
| 2018-06-30 | -2.18% | GBX-492.00K ≈ $-59.86 |
GBX22.54 Million ≈ $2.74K |
-- |
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more